Adagrasib,Cetuximab,Afatinib,Pembrolizumab
Eli Lilly,Boehringer Ingelheim,Merck,Mirati Therapeutics
['adagrasib', 'thanks']
commentary on paper adagrasib in advanced solid tumors harboring a krasg12c mutation thanks to for invite to write the editorial 
Chief, Early-Phase Drug Development|@SarahCannonDocs
#Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.